Explore a range of clinical and educational resources related to the use of vutrisiran in adult patients with the polyneuropathy of hereditary ATTR (hATTR, also known as ATTRv) amyloidosis or with the cardiomyopathy of wild-type or hereditary ATTR amyloidosis
A short summary of HELIOS‑B primary medical and scientific publications (including peer-reviewed medical journal articles and scientific conference presentations)
You are now leaving this site and being directed to a third-party website that is not maintained by Alnylam. Alnylam does not endorse and is not responsible for content or maintenance of third-party websites.
Navigating to another Alnylam website
You are now leaving this site and being directed to another Alnylam website.
Share this resource
OR
Search for educational content on Disease & Therapeutic Areas and Alnylam Therapies
Use the "Search" feature to discover Disease & Therapeutic Area educational content based on key terms
More than one search term is recommended to yield the most relevant results
By searching, you confirm that your query is unsolicited
We’re sorry, no results were found for your search: Hypertnghy
For further information regarding your request, please connect with us
Intended for US healthcare professionals. This site is intended to provide balanced, evidence-based information to support scientific exchange. It is not intended to provide medical advice or recommendations for clinical practice.
Information about investigational therapeutics or investigational uses of approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of FDA approval.
Alnylam does not recommend or suggest use of its products in any manner inconsistent with the approved Prescribing Information.
Are you a healthcare professional practicing in the United States?
